vTv Therapeutics (VTVT)

vTv Therapeutics (VTVT) Stock Price & Analysis


VTVT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.41 - $1.05
Previous Close$0.43
Average Volume (3M)169.93K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$12.60M
Total Debt (Recent Filing)$417.00K
Price to Earnings (P/E)-1.8
Nov 09, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding104,577,460
10 Day Avg. Volume43,875
30 Day Avg. Volume169,928
Standard Deviation0.38
Financial Highlights & Ratios
Price to Book (P/B)-1.93
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was vTv Therapeutics’s price range in the past 12 months?
vTv Therapeutics lowest stock price was $0.41 and its highest was $1.05 in the past 12 months.
    What is vTv Therapeutics’s market cap?
    Currently, no data Available
    When is vTv Therapeutics’s upcoming earnings report date?
    vTv Therapeutics’s upcoming earnings report date is Nov 09, 2023 which is in 47 days.
      How were vTv Therapeutics’s earnings last quarter?
      vTv Therapeutics released its earnings results on Aug 11, 2023. The company reported -$0.07 earnings per share for the quarter, the consensus estimate of -$0.07 by $0.
        Is vTv Therapeutics overvalued?
        According to Wall Street analysts vTv Therapeutics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does vTv Therapeutics pay dividends?
          vTv Therapeutics does not currently pay dividends.
          What is vTv Therapeutics’s EPS estimate?
          vTv Therapeutics’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does vTv Therapeutics have?
          vTv Therapeutics has 81,483,600 shares outstanding.
            What happened to vTv Therapeutics’s price movement after its last earnings report?
            vTv Therapeutics reported an EPS of -$0.07 in its last earnings report, expectations of -$0.07. Following the earnings report the stock price went up 2.778%.
              Which hedge fund is a major shareholder of vTv Therapeutics?
              Currently, no hedge funds are holding shares in VTVT


              vTv Therapeutics Stock Smart Score

              The vTv Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              vTv Therapeutics

              vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.


              Top 5 ETFs holding VTVT

              Market Value
              Smart Score
              Vanguard Total Stock Market ETF
              iShares Core S&P Total U.S. Stock Market ETF
              Up to five ETFs with an Outperform Smart Score that hold VTVT. The ETFs are listed according to market value of VTVT within the ETF

              Forecast EPS vs Actual EPS

              Similar Stocks
              Price & Change
              Fate Therapeutics

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis